IQVIA Holdings Inc. (IQV)$167.90
Market Cap: 26.85 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for IQVIA Holdings Inc. (IQV).
HEALTHCARE
DIAGNOSTICS & RESEARCH
DCF ready
Valuation
12.1x
EV/FCF, 8.2% FCF yield
Quality
20.9%
ROIC, 12.6% FCF margin
Growth
7.5%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 0.7x current ratio
Superinvestors
3
Top: Bill Nygren (2.8%)
Strengths to research
- Free cash flow compounded at 8.8% over five years.
- Return on equity is strong at 20.9%.
- Free cash flow margin is healthy at 12.6%.
- Debt/equity looks manageable at 0.0x.
Watchouts
- Current ratio is below 1 at 0.7x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for IQV.
Grade B
80
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| IQV Target | IQVIA Holdings Inc. | $26.9B | 21.4x | 12.1x | 20.9% | 7.5% | 12.6% | N/A | -0.6x | N/A |
| A | Agilent Technologies | $30.9B | 25.2x | 27.9x | 13.3% | 5.4% | 16.6% | N/A | 0.7x | N/A |
| MTD | Mettler-Toledo International Inc. | $22.7B | 26.2x | 29.2x | 42.1% | 5.5% | 21.1% | 59.4% | N/A | N/A |
| NTRA | Natera Inc. | $21.4B | -133.7x | 186.2x | -12.2% | 42.6% | 4.7% | N/A | N/A | N/A |
| LH | Labcorp Holdings Inc. | $20.7B | 24.8x | 16.7x | 10.2% | -0.0% | 8.6% | 28.8% | -0.3x | N/A |
| DGX | Quest Diagnostics | $19.8B | 22.3x | 18.5x | 7.7% | 3.2% | 12.3% | N/A | 2.5x | N/A |
| IDXX | IDEXX Laboratories | $38.2B | 42.8x | 36.4x | 51.5% | 9.7% | 24.6% | 61.8% | 0.2x | N/A |
| LZAGY | Lonza Group Ag Unspon ADR | $52.5B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ILMN | Illumina Inc. | $12.4B | 26.5x | 11.8x | 31.2% | 6.0% | 21.4% | 66.1% | -1.3x | N/A |
Financial Charts
No financial data available for IQV (annual).
3 superinvestors own IQV
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Bill Nygren Oakmark Select Fund | 12,183,275 | $2.1B | 2.77% | 0.0% |
| William Von Mueffling Cantillon Capital Management | 1,710,896 | $292M | 1.94% | 0.0% |
| Thomas Gayner Markel Group | 46,900 | $8M | 0.07% | 0.0% |